Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression

NCT04798612 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Pegasys
DRUG: Saline

Sponsor

Zealand University Hospital

Collaborators

[object Object]